{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:31:35Z","timestamp":1793295095485,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["RS-2025-02214129"],"award-info":[{"award-number":["RS-2025-02214129"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"DOI":"10.1007\/s40290-026-00635-9","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T13:56:23Z","timestamp":1788702983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From Invisible to Enrolled: How Artificial Intelligence Is Reshaping Clinical Trial Recruitment"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2749-0014","authenticated-orcid":false,"given":"Sangzin","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"635_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2026.01.010","author":"T Martyn","year":"2026","unstructured":"Martyn T, Hanna M, Nissen SE, Patolia H, Rajendran J, Sun W, et al. Automating chart review using an artificial intelligence-enabled system for assessing transthyretin amyloid cardiomyopathy trial eligibility. J Card Fail. 2026. https:\/\/doi.org\/10.1016\/j.cardfail.2026.01.010.","journal-title":"J Card Fail"},{"issue":"18","key":"635_CR2","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1200\/JCO.23.01030","volume":"42","author":"JM Unger","year":"2024","unstructured":"Unger JM, Shulman LN, Facktor MA, Nelson H, Fleury ME. National estimates of the participation of patients with cancer in clinical research studies based on Commission on Cancer accreditation data. J Clin Oncol. 2024;42(18):2139\u201348. https:\/\/doi.org\/10.1200\/JCO.23.01030.","journal-title":"J Clin Oncol"},{"key":"635_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-14-166","volume":"14","author":"BGO Sully","year":"2013","unstructured":"Sully BGO, Julious SA, Nicholl J. A reinvestigation of recruitment to randomised, controlled, multicenter trials: a review of trials funded by two UK funding agencies. Trials. 2013;14:166. https:\/\/doi.org\/10.1186\/1745-6215-14-166.","journal-title":"Trials"},{"key":"635_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jclinepi.2016.07.016","volume":"80","author":"M Briel","year":"2016","unstructured":"Briel M, Olu KK, von Elm E, Kasenda B, Alturki R, Agarwal A, et al. A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable. J Clin Epidemiol. 2016;80:8\u201315. https:\/\/doi.org\/10.1016\/j.jclinepi.2016.07.016.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"635_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/eahr.60014","volume":"47","author":"L Bernasconi","year":"2025","unstructured":"Bernasconi L, Avakyan G, Hovaguimian F, Grossmann R. Natural language processing in clinical research recruitment: a scoping review enriched with stakeholder insights. Ethics Hum Res. 2025;47(5):13\u201323. https:\/\/doi.org\/10.1002\/eahr.60014.","journal-title":"Ethics Hum Res"},{"issue":"1","key":"635_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12916-025-04348-9","volume":"23","author":"A Lin","year":"2025","unstructured":"Lin A, Wang Z, Jiang A, Chen L, Qi C, Zhu L, et al. Large language models in clinical trials: applications, technical advances, and future directions. BMC Med. 2025;23(1):563. https:\/\/doi.org\/10.1186\/s12916-025-04348-9.","journal-title":"BMC Med"},{"issue":"1","key":"635_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41698-026-01306-3","volume":"10","author":"D Horgan","year":"2026","unstructured":"Horgan D, Paulson JN, Loaiza-Bonilla A, Svedman C, Malapelle U, Penault-Llorca F, et al. A unified framework for pre-screening and screening tools in oncology clinical trials. NPJ Precis Oncol. 2026;10(1):143. https:\/\/doi.org\/10.1038\/s41698-026-01306-3.","journal-title":"NPJ Precis Oncol."},{"key":"635_CR8","doi-asserted-by":"publisher","DOI":"10.1200\/CCI-25-00071","volume":"9","author":"H Chen","year":"2025","unstructured":"Chen H, Li X, He X, Chen A, McGill J, Webber EC, et al. Enhancing patient-trial matching with large language models: a scoping review of emerging applications and approaches. JCO Clin Cancer Inform. 2025;9:e2500071. https:\/\/doi.org\/10.1200\/CCI-25-00071.","journal-title":"JCO Clin Cancer Inform."},{"key":"635_CR9","doi-asserted-by":"publisher","DOI":"10.2196\/80268","volume":"12","author":"A Claessens","year":"2026","unstructured":"Claessens A, Simon A, Manchart A, Desmonts L, Leguay C, Faivre JC, et al. AI-driven patient screening for clinical trials in pancreatic cancer: the PANCR-AI pilot retrospective comparative study. JMIR Cancer. 2026;12:e80268. https:\/\/doi.org\/10.2196\/80268.","journal-title":"JMIR Cancer."},{"issue":"1","key":"635_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-01256-0","volume":"5","author":"A Callies","year":"2025","unstructured":"Callies A, Bodinier Q, Ravaud P, Davarpanah K. Real-world validation of a multimodal LLM-powered pipeline for high-accuracy clinical trial patient matching. Commun Med (Lond). 2025;5(1):536. https:\/\/doi.org\/10.1038\/s43856-025-01256-0.","journal-title":"Commun Med (Lond)"},{"issue":"1","key":"635_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01681-4","volume":"8","author":"EG Woo","year":"2025","unstructured":"Woo EG, Burkhart MC, Alsentzer E, Beaulieu-Jones BK. Synthetic data distillation enables the extraction of clinical information at scale. NPJ Digit Med. 2025;8(1):267. https:\/\/doi.org\/10.1038\/s41746-025-01681-4.","journal-title":"NPJ Digit Med"},{"issue":"2","key":"635_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0341827","volume":"21","author":"L Yang","year":"2026","unstructured":"Yang L, Han Y, Liu L, Jiang X, Li Y, Huang J, et al. EC2Seq2Sql: patient-trial matching with LLM agents. PLoS ONE. 2026;21(2):e0341827. https:\/\/doi.org\/10.1371\/journal.pone.0341827.","journal-title":"PLoS ONE"},{"issue":"12","key":"635_CR13","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1001\/jama.2024.28047","volume":"333","author":"O Unlu","year":"2025","unstructured":"Unlu O, Varugheese M, Shin J, Subramaniam SM, Stein DWJ, St Laurent JJ, et al. Manual vs AI-assisted prescreening for trial eligibility using large language models: a randomized clinical trial. JAMA. 2025;333(12):1084\u20137. https:\/\/doi.org\/10.1001\/jama.2024.28047.","journal-title":"JAMA"},{"issue":"1","key":"635_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53081-z","volume":"15","author":"Q Jin","year":"2024","unstructured":"Jin Q, Wang Z, Floudas CS, Chen F, Gong C, Bracken-Clarke D, et al. Matching patients to clinical trials with large language models. Nat Commun. 2024;15(1):9074. https:\/\/doi.org\/10.1038\/s41467-024-53081-z.","journal-title":"Nat Commun"},{"issue":"4","key":"635_CR15","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/jamia\/ocag006","volume":"33","author":"M Syed","year":"2026","unstructured":"Syed M, Hamidi M, Bikkanuri M, Dierschke NA, Katragadda HV, Zozus M, et al. Translating evidence into practice: adapting TrialGPT for real-world clinical trial eligibility screening. J Am Med Inform Assoc. 2026;33(4):909\u201313. https:\/\/doi.org\/10.1093\/jamia\/ocag006.","journal-title":"J Am Med Inform Assoc"},{"key":"635_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmorw.2026.100706","volume":"12","author":"A Loaiza-Bonilla","year":"2026","unstructured":"Loaiza-Bonilla A, Yost C, Kurnaz S, Tuysuz E, Thaker NG, Giritlioglu D, et al. Transforming oncology clinical trial matching through neuro-symbolic, multi-agent AI and an oncology-specific knowledge graph: a prospective evaluation in 3804 patients. ESMO Real World Data Digit Oncol. 2026;12:100706. https:\/\/doi.org\/10.1016\/j.esmorw.2026.100706.","journal-title":"ESMO Real World Data Digit Oncol."},{"issue":"1","key":"635_CR17","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1038\/s41467-026-70509-w","volume":"17","author":"M Abdallah","year":"2026","unstructured":"Abdallah M, Nakken S, Georges M, Bierkens M, Galvis J, Groppi A, et al. TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching. Nat Commun. 2026;17(1):4472. https:\/\/doi.org\/10.1038\/s41467-026-70509-w.","journal-title":"Nat Commun"},{"key":"635_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2025.109915","volume":"191","author":"CT Verhagen","year":"2026","unstructured":"Verhagen CT, Westerman G, Heaviland H, Lynch E, Brandenburg O, Adams-Patton J, et al. Understanding unrealized trial enrollments following patient-to-trial matching with large language models. Surgery. 2026;191:109915. https:\/\/doi.org\/10.1016\/j.surg.2025.109915.","journal-title":"Surgery"},{"key":"635_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/CCI-25-00028","volume":"10","author":"M Guo","year":"2026","unstructured":"Guo M, Passalacqua E, Bao E, Miao B, Butte A, Zack T. Exploring the past and current landscape of biomarker-driven clinical trials through large language models. JCO Clin Cancer Inform. 2026;10:e2500028. https:\/\/doi.org\/10.1200\/CCI-25-00028.","journal-title":"JCO Clin Cancer Inform"},{"issue":"3","key":"635_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300109","volume":"19","author":"L Hulstaert","year":"2024","unstructured":"Hulstaert L, Twick I, Sarsour K, Verstraete H. Enhancing site selection strategies in clinical trial recruitment using real-world data modeling. PLoS ONE. 2024;19(3):e0300109. https:\/\/doi.org\/10.1371\/journal.pone.0300109.","journal-title":"PLoS ONE"},{"key":"635_CR21","doi-asserted-by":"publisher","DOI":"10.2196\/67469","volume":"27","author":"L Jin","year":"2025","unstructured":"Jin L, Ong JCL, Elangovan K, Ke Y, Pyle A, Ting DSW, et al. Large language models in randomized controlled trials design: observational study. J Med Internet Res. 2025;27:e67469. https:\/\/doi.org\/10.2196\/67469.","journal-title":"J Med Internet Res"},{"issue":"4","key":"635_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ocarto.2023.100406","volume":"5","author":"P Widera","year":"2023","unstructured":"Widera P, Welsing PMJ, Danso SO, Peelen S, Kloppenburg M, Loef M, et al. Development and validation of a machine learning-supported strategy of patient selection for osteoarthritis clinical trials: the IMI-APPROACH study. Osteoarthr Cartil Open. 2023;5(4):100406. https:\/\/doi.org\/10.1016\/j.ocarto.2023.100406.","journal-title":"Osteoarthr Cartil Open"},{"issue":"2","key":"635_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70084","volume":"11","author":"S Gladstein","year":"2025","unstructured":"Gladstein S, Yang L, Wooten D, Huang X, Comley R, Guo Q, et al. Machine learning-enhanced screening funnel for clinical trials in Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2025;11(2):e70084. https:\/\/doi.org\/10.1002\/trc2.70084.","journal-title":"Alzheimers Dement (N Y)."},{"issue":"5","key":"635_CR24","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jhep.2024.11.032","volume":"82","author":"D Abdurrachim","year":"2025","unstructured":"Abdurrachim D, Lek S, Ong CZL, Wong CK, Zhou Y, Wee A, et al. Utility of AI digital pathology as an aid for pathologists scoring fibrosis in MASH. J Hepatol. 2025;82(5):898\u2013908. https:\/\/doi.org\/10.1016\/j.jhep.2024.11.032.","journal-title":"J Hepatol"},{"issue":"11","key":"635_CR25","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/jamia\/ocz064","volume":"26","author":"J Gligorijevic","year":"2019","unstructured":"Gligorijevic J, Gligorijevic D, Pavlovski M, Milkovits E, Glass L, Grier K, et al. Optimizing clinical trials recruitment via deep learning. J Am Med Inform Assoc. 2019;26(11):1195\u2013202. https:\/\/doi.org\/10.1093\/jamia\/ocz064.","journal-title":"J Am Med Inform Assoc"},{"issue":"3","key":"635_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.patter.2024.100944","volume":"5","author":"B Theodorou","year":"2024","unstructured":"Theodorou B, Glass L, Xiao C, Sun J. FRAMM: fair ranking with missing modalities for clinical trial site selection. Patterns (N Y). 2024;5(3):100944. https:\/\/doi.org\/10.1016\/j.patter.2024.100944.","journal-title":"Patterns (N Y)."},{"issue":"3","key":"635_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s44360-026-00073-6","volume":"1","author":"J Gao","year":"2026","unstructured":"Gao J, Xiao C, Glass LM, Harrison EM, Sun J. Matching clinicians with clinical trials using AI. Nat Health. 2026;1(3):290\u20139. https:\/\/doi.org\/10.1038\/s44360-026-00073-6.","journal-title":"Nat Health"},{"key":"635_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2026.106314","volume":"211","author":"Z Yang","year":"2026","unstructured":"Yang Z. Machine learning for site risk prediction in clinical trials: development, external validation, and operational application in site qualification. Int J Med Inform. 2026;211:106314. https:\/\/doi.org\/10.1016\/j.ijmedinf.2026.106314.","journal-title":"Int J Med Inform"},{"issue":"2024","key":"635_CR29","first-page":"228","volume":"22","author":"J Chan","year":"2025","unstructured":"Chan J, Jin Q, Wan N, Floudas CS, Xue E, Lu Z. Recommending clinical trials for online patient cases using artificial intelligence. AMIA Annu Symp Proc. 2025;22(2024):228\u201337.","journal-title":"AMIA Annu Symp Proc"},{"issue":"3","key":"635_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.12793\/tcp.2023.31.e16","volume":"31","author":"JL Ghim","year":"2023","unstructured":"Ghim JL, Ahn S. Transforming clinical trials: the emerging roles of large language models. Transl Clin Pharmacol. 2023;31(3):131\u20138. https:\/\/doi.org\/10.12793\/tcp.2023.31.e16.","journal-title":"Transl Clin Pharmacol"},{"issue":"5","key":"635_CR31","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jid.2024.10.615","volume":"145","author":"YJ Park","year":"2025","unstructured":"Park YJ, Omiye JA, Ma B, Chan AW, Daneshjou R. Leveraging large language models to enhance dermatology clinical trial patient recruitment and retention. J Invest Dermatol. 2025;145(5):1002\u20134. https:\/\/doi.org\/10.1016\/j.jid.2024.10.615.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"635_CR32","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/jamia\/ocag058","volume":"33","author":"S Soffer","year":"2026","unstructured":"Soffer S, Omar M, Efros O, Apakama DU, Mudrik A, Freeman R, et al. Sociodemographic bias in large language model clinical trial screening. J Am Med Inform Assoc. 2026;33(8):1504\u20139. https:\/\/doi.org\/10.1093\/jamia\/ocag058.","journal-title":"J Am Med Inform Assoc"},{"issue":"1","key":"635_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-025-00458-5","volume":"18","author":"X Gui","year":"2025","unstructured":"Gui X, Lv H, Wang X, Lv L, Xiao Y, Wang L. Enhancing hepatopathy clinical trial efficiency: a secure, large language model-powered pre-screening pipeline. BioData Min. 2025;18(1):42. https:\/\/doi.org\/10.1186\/s13040-025-00458-5.","journal-title":"BioData Min"},{"issue":"1","key":"635_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000082","volume":"2","author":"A Gonzales","year":"2023","unstructured":"Gonzales A, Guruswamy G, Smith SR. Synthetic data in health care: a narrative review. PLOS Digit Health. 2023;2(1):e0000082. https:\/\/doi.org\/10.1371\/journal.pdig.0000082.","journal-title":"PLOS Digit Health"},{"key":"635_CR35","unstructured":"U.S. Food and Drug Administration. E6(R3) good clinical practice (GCP): guidance for industry. 2025. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/e6r3-good-clinical-practice-gcp. Accessed 28 Apr 2026."},{"key":"635_CR36","unstructured":"U.S. Food and Drug Administration. Artificial intelligence in software as a medical device. 2025. https:\/\/www.fda.gov\/medical-devices\/software-medical-device-samd\/artificial-intelligence-software-medical-device. Accessed 28 Apr 2026."},{"key":"635_CR37","unstructured":"U.S. Food and Drug Administration. Marketing submission recommendations for a predetermined change control plan for artificial intelligence-enabled device software functions: guidance for industry and food and drug administration staff. 2025. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/marketing-submission-recommendations-predetermined-change-control-plan-artificial-intelligence. Accessed 28 Apr 2026."},{"key":"635_CR38","unstructured":"U.S. Food and Drug Administration. Clinical decision support software: guidance for industry and food and drug administration staff. 2026. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-decision-support-software. Accessed 10 Jul 2026."},{"key":"635_CR39","unstructured":"U.S. Food and Drug Administration. Considerations for the use of artificial intelligence to support regulatory decision-making for drug and biological products: draft guidance for industry and other interested parties. 2025. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/considerations-use-artificial-intelligence-support-regulatory-decision-making-drug-and-biological. Accessed 28 Apr 2026."},{"key":"635_CR40","unstructured":"European Medicines Agency. Reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle. 2024. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-use-artificial-intelligence-ai-medicinal-product-lifecycle_en.pdf. Accessed 28 Apr 2026."},{"key":"635_CR41","unstructured":"U.S. Food and Drug Administration. Guiding principles of good AI practice in drug development. 2026. https:\/\/www.fda.gov\/about-fda\/artificial-intelligence-drug-development\/guiding-principles-good-ai-practice-drug-development. Accessed 28 Apr 2026."},{"key":"635_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-020-00323-1","volume":"3","author":"N Rieke","year":"2020","unstructured":"Rieke N, Hancox J, Li W, Milletari F, Roth HR, Albarqouni S, et al. The future of digital health with federated learning. NPJ Digit Med. 2020;3:119. https:\/\/doi.org\/10.1038\/s41746-020-00323-1.","journal-title":"NPJ Digit Med"}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-026-00635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-026-00635-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-026-00635-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T13:56:25Z","timestamp":1788702985000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40290-026-00635-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,6]]},"references-count":42,"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1007\/s40290-026-00635-9","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,6]]},"assertion":[{"value":"13 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author has no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.A. conceived the article, led the literature review and evidence synthesis, drafted the manuscript, critically revised the work, and approved the final manuscript.","order":2,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not report original research data.","order":3,"name":"Ethics","label":"Data Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author used OpenAI Codex and Anthropic Claude to support literature organization, evidence mapping, outlining, drafting assistance, and editorial revision. The author reviewed and verified all AI-assisted outputs and takes full responsibility for the final content.","order":4,"name":"Ethics","label":"AI Tool Use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":7,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":8,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}